Home blood pressure monitoring for heart pump patients
Part of Heart & circulation clinical trials.
This trial tests a special blood pressure monitor (called a sphygmomanometer) that measures blood pressure very slowly, designed for people with a HeartMate 3 LVAD. The goal is to see if it's practical and helpful for monitoring blood pressure at home, which can help manage your heart health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a HeartMate 3 (HM3) LVAD, which is a type of mechanical heart pump.
- You must be over 18 years old.
- Your kidney function must be good (eGFR of 30 or higher).
- You must be able to get blood pressure readings on both arms.
- You cannot be on IV heart-support medications called inotropes.
- You must not have severe cognitive or vision problems that would make it hard to use the blood pressure device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a small sensor (CardioMEMS) implanted in the lung artery can help doctors better manage LVAD settings and reduce hospital visits. It is for people who already have a HeartMate 3 heart pump and are stable enough to go home.
This study tests whether using a new wearable, cuffless blood pressure monitor (worn on the wrist or finger) to guide treatment can better control high blood pressure compared to usual office checkups. It may help you manage your pressure more conveniently and effectively.
This study checks whether a noninvasive ultrasound-based method can help diagnose what’s going on in people with a HeartMate 3 blood pump. It may help detect important pump-related changes while keeping the process safer for certain high-risk situations.
This study tests a new wearable device that measures blood pressure without a cuff. You might be able to join if you are generally healthy, not pregnant, and have no serious heart or kidney problems.
This trial tests a wearable device that tracks your blood pressure continuously without extra pokes, compared to the standard arterial line. It could make monitoring more comfortable during your procedure.
This trial tests a wirelessly implanted device that measures pressure in the left upper heart chamber (left atrial pressure) in people with advanced heart failure. By tracking that pressure, researchers hope to better understand disease status and guide care.
Hear when a new LVAD (Left Ventricular Assist Device) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.